Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02615912
NCT02615912
Completed
Not Applicable

A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants

Kimberly-Clark Corporation1 site in 1 country24 target enrollmentNovember 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDermatitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dermatitis
Sponsor
Kimberly-Clark Corporation
Enrollment
24
Locations
1
Primary Endpoint
Amount of microbes present on skin after exposure to various surfactants
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to understand the changes in skin microflora, skin barrier function, and skin biochemical constituents in response to direct contact with model surfactants used in personal care articles. The results from this study will provide insights into the complex interaction between the skin microbiome and the epidermis after exposure to surfactants.

Registry
clinicaltrials.gov
Start Date
November 2015
End Date
February 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Healthy Subjects with Fitzpatrick Skin Types I, II or III

Exclusion Criteria

  • •Subjects with visible skin disease, tattoos, skin condition, or abnormal skin color

Outcomes

Primary Outcomes

Amount of microbes present on skin after exposure to various surfactants

Time Frame: 4 days

Type of microbes present on skin after exposure to various surfactants

Time Frame: 4 days

Microbes will be identified by metagenomic sequencing

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Wound Healing in Healthy VolunteersWound Healing
NCT03433820Centre for Human Drug Research, Netherlands18
Unknown
Not Applicable
Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)Eczema
NCT05413395GlycosBio, Inc.60
Completed
Phase 4
Profiling the Skin Microbiome in Response to Altreno in Acne PatientsAcneHealthy
NCT04548349Beth Israel Deaconess Medical Center25
Unknown
Not Applicable
Skin Barrier Abnormalities and Oxidative Stress ResponseAtopic DermatitisFood Allergy
NCT04606615National Jewish Health160
Completed
Phase 4
Study of the Combination of a Cyanoacrylate and Surgical Solutions in Reducing Skin Flora ContaminationSkin Flora Contamination
NCT00467857Kimberly-Clark Corporation293